(October 28, 2019, 10:45 AM EDT) -- WASHINGTON, D.C. — In an Oct. 24 appellant brief, Merck, Sharp & Dohme Corp. maintains that the Patent Trial and Appeal Board erred in confirming as patentable various claims of three...
Merck Disputes Patent Board Findings In Federal Circuit Appeal
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login